The Journal of Pediatrics 1993-10-01

Molybdenum cofactor deficiency.

G L Arnold, C L Greene, J P Stout, S I Goodman

Index: J. Pediatr. 123(4) , 595-8, (1993)

Full Text: HTML

Abstract

We describe a new case of molybdenum cofactor deficiency, an underrecognized inborn error of metabolism that results in neonatal seizures and neurologic abnormalities. Characteristic biochemical defects in affected individuals include hypouricemia, elevated urine sulfate (detectable by dipstick), and elevated S-sulfocysteine (detectable by anion exchange chromatography). This disorder should be considered in the differential diagnosis of neonatal seizures.


Related Compounds

Related Articles:

Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement.

2000-02-01

[J. Inherit. Metab. Dis. 23(1) , 45-53, (2000)]

Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency.

2012-11-01

[J. Inherit. Metab. Dis. 35(6) , 1031-6, (2012)]

Molybdenum cofactor deficiency: metabolic link between taurine and S-sulfocysteine.

2013-01-01

[Adv. Exp. Med. Biol. 776 , 13-9, (2013)]

Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli.

1996-01-01

[Protein Eng. 9(1) , 101-6, (1996)]

Pyridoxal 5'-phosphate in cerebrospinal fluid; factors affecting concentration.

2011-04-01

[J. Inherit. Metab. Dis. 34(2) , 529-38, (2011)]

More Articles...